Interleukin 10- and Fcgamma Receptor-deficient Mice Resolve Leishmania Mexicana Lesions

Overview

Journal Infect Immun

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 2005 Mar 24

PMID 15784551

Citations 41

Authors

Laurence U Buxbaum

Phillip Scott

Affiliations

Soon will be listed here.

Abstract

Infection of C57BL/6 (B6) mice with Leishmania mexicana is associated with a minimal immune response and chronic disease. Here we show that B6 interleukin 10-/- (IL-10-/-) mice resolve their lesions and exhibit increased gamma interferon (IFN-gamma), nitric oxide production, and delayed-type hypersensitivity. This enhanced resistance was dependent upon IL-12p40, since treatment of L. mexicana-infected IL-10-/- mice with anti-IL-12p40 monoclonal antibody abrogated healing. Antibody-opsonized L. mexicana induced IL-10 production by B6 macrophages in vitro, implicating antibody binding to Fc receptors as a mechanism involved in IL-10 production in this infection. Furthermore, B6 FcRgamma-/- mice resolve L. mexicana lesions, and lymph node cells from these mice produced less IL-10 and more IFN-gamma than cells from infected wild-type mice. These data demonstrate that removal of IL-10 or FcgammaR leads to resolution of L. mexicana disease and support a model in which ligation of FcgammaR by L. mexicana-bound immunoglobulin G promotes IL-10 production, leading to chronic disease.

Citing Articles

promotes pain-reducing metabolomic reprogramming in cutaneous lesions.

Volpedo G, Oljuskin T, Cox B, Mercado Y, Askwith C, Azodi N iScience. 2023; 26(12):108502.

PMID: 38125023 PMC: 10730346. DOI: 10.1016/j.isci.2023.108502.

The cytokine/chemokine response in /HIV infection and co-infection.

Maksoud S, Hokayem J Heliyon. 2023; 9(4):e15055.

PMID: 37082641 PMC: 10112040. DOI: 10.1016/j.heliyon.2023.e15055.

Humoral response in Leishmaniasis.

Conde L, Maciel G, de Assis G, Freire-de-Lima L, Nico D, Vale A Front Cell Infect Microbiol. 2022; 12:1063291.

PMID: 36579347 PMC: 9791258. DOI: 10.3389/fcimb.2022.1063291.

Centrin-deficient Leishmania mexicana confers protection against New World cutaneous leishmaniasis.

Volpedo G, Pacheco-Fernandez T, Holcomb E, Zhang W, Lypaczewski P, Cox B NPJ Vaccines. 2022; 7(1):32.

PMID: 35236861 PMC: 8891280. DOI: 10.1038/s41541-022-00449-1.

Potential biomarkers of immune protection in human leishmaniasis.

Nateghi Rostami M, Khamesipour A Med Microbiol Immunol. 2021; 210(2-3):81-100.

PMID: 33934238 PMC: 8088758. DOI: 10.1007/s00430-021-00703-8.

References

Buxbaum L, Denise H, Coombs G, Alexander J, Mottram J, Scott P . Cysteine protease B of Leishmania mexicana inhibits host Th1 responses and protective immunity. J Immunol. 2003; 171(7):3711-7. DOI: 10.4049/jimmunol.171.7.3711. View

Padigel U, Alexander J, Farrell J . The role of interleukin-10 in susceptibility of BALB/c mice to infection with Leishmania mexicana and Leishmania amazonensis. J Immunol. 2003; 171(7):3705-10. DOI: 10.4049/jimmunol.171.7.3705. View

Rouzer C, Scott W, Kempe J, COHN Z . Prostaglandin synthesis by macrophages requires a specific receptor-ligand interaction. Proc Natl Acad Sci U S A. 1980; 77(7):4279-82. PMC: 349816. DOI: 10.1073/pnas.77.7.4279. View

Tushinski R, Oliver I, Guilbert L, Tynan P, Warner J, Stanley E . Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroy. Cell. 1982; 28(1):71-81. DOI: 10.1016/0092-8674(82)90376-2. View

Green L, Wagner D, Glogowski J, Skipper P, Wishnok J, Tannenbaum S . Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem. 1982; 126(1):131-8. DOI: 10.1016/0003-2697(82)90118-x. View

Warren M, Vogel S . Bone marrow-derived macrophages: development and regulation of differentiation markers by colony-stimulating factor and interferons. J Immunol. 1985; 134(2):982-9. View

Alexander J, Kaye P . Immunoregulatory pathways in murine leishmaniasis: different regulatory control during Leishmania mexicana mexicana and Leishmania major infections. Clin Exp Immunol. 1985; 61(3):674-82. PMC: 1577261. View

Farrell J, Kirkpatrick C . Experimental cutaneous leishmaniasis. II. A possible role for prostaglandins in exacerbation of disease in Leishmania major-infected BALB/c mice. J Immunol. 1987; 138(3):902-7. View

Scott P, Pearce E, Natovitz P, Sher A . Vaccination against cutaneous leishmaniasis in a murine model. II. Immunologic properties of protective and nonprotective subfractions of soluble promastigote extract. J Immunol. 1987; 139(9):3118-25. View

10.

Heinzel F, Sadick M, Holaday B, Coffman R, Locksley R . Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J Exp Med. 1989; 169(1):59-72. PMC: 2189187. DOI: 10.1084/jem.169.1.59. View

11.

Barral-Netto M, Barral A, Brownell C, Skeiky Y, Ellingsworth L, Twardzik D . Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism. Science. 1992; 257(5069):545-8. DOI: 10.1126/science.1636092. View

12.

Afonso L, Scott P . Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis. Infect Immun. 1993; 61(7):2952-9. PMC: 280944. DOI: 10.1128/iai.61.7.2952-2959.1993. View

13.

Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W . Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 1993; 75(2):263-74. DOI: 10.1016/0092-8674(93)80068-p. View

14.

Scharton-Kersten T, Afonso L, Wysocka M, Trinchieri G, Scott P . IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J Immunol. 1995; 154(10):5320-30. View

15.

Reiner S, Locksley R . The regulation of immunity to Leishmania major. Annu Rev Immunol. 1995; 13:151-77. DOI: 10.1146/annurev.iy.13.040195.001055. View

16.

Satoskar A, Bluethmann H, Alexander J . Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection. Infect Immun. 1995; 63(12):4894-9. PMC: 173701. DOI: 10.1128/iai.63.12.4894-4899.1995. View

17.

Ghetie V, Hubbard J, Kim J, Tsen M, Lee Y, Ward E . Abnormally short serum half-lives of IgG in beta 2-microglobulin-deficient mice. Eur J Immunol. 1996; 26(3):690-6. DOI: 10.1002/eji.1830260327. View

18.

Marcotte H, Levesque D, Delanay K, Bourgeault A, de la Durantaye R, Brochu S . Pneumocystis carinii infection in transgenic B cell-deficient mice. J Infect Dis. 1996; 173(4):1034-7. DOI: 10.1093/infdis/173.4.1034. View

19.

Junghans R, Anderson C . The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor. Proc Natl Acad Sci U S A. 1996; 93(11):5512-6. PMC: 39277. DOI: 10.1073/pnas.93.11.5512. View

20.

Gazzinelli R, Wysocka M, Hieny S, Scharton-Kersten T, Cheever A, Kuhn R . In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J Immunol. 1996; 157(2):798-805. View